✦ LIBER ✦

Ascorbic acid recycling in Nb2 lymphoma cells: implications for tumor progression

✍ Scribed by Ann M. Bode; Hanqian Q. Liang; Edie H. Green; Tim E. Meyer; Donna J. Buckley; Anne Norris; Peter W. Gout; Arthur R. Buckley

Book ID: 114277034
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 559 KB
Volume: 26
Category: Article
ISSN: 0891-5849
DOI: 10.1016/s0891-5849(98)00183-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Requirement for GSH in recycling of asco

Requirement for GSH in recycling of ascorbic acid in endothelial cells

✍ James M May; Zhi-chao Qu; Xia Li 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Vascular endothelial growth factor-A sti

Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: Implications for tumor progression

✍ Luke S. Wanami; Hsin-Ying Chen; Sandra Peiró; Antonio García de Herreros; Robin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 496 KB

System A amino acid transport in culture

System A amino acid transport in cultured human tumor cells: Implications for tumor imaging with PET

✍ James R. Bading; June Kan-Mitchell; Peter S. Conti 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 999 KB

Changes in activatory and inhibitory nat

Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: Implications for tumor evasion of T and NK cells

✍ Mónica Bernal; Pilar Garrido; Pilar Jiménez; Rafael Carretero; Manuel Almagro; P 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 811 KB

Expression of HLA class I, β2-microglobu

Expression of HLA class I, β2-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism

✍ Lijun Shen; Alan K.S. Chiang; Wei Ping Liu; Gan Di Li; Raymond H.S. Liang; Gopes 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 536 KB

Several mechanisms of immune escape might be in operation in Epstein-Barr virus (EBV)-associated nasal NK/T-cell lymphoma. We have previously shown the downregulation of the immunogenic EBV nuclear antigens by alternative promoter usage and the preferential selection of the deletion genotype of late